Ayass BioScience, LLC was established in 2014 with a mission to provide early disease detection, develop a disease monitoring system, and ultimately achieve better patient outcomes by implementing Molecular Modern Medicine to daily clinical practice. We emphasize on Pathophysiology, Genetic, Epigenetic, and Proteomic/Metabolic profiling by conducting comprehensive immunologic testing, next-generation sequencing, and mass spectrometry assays.
Data collection and, more importantly, data interpretation through our bioinformatics and biostatistics department provides meaningful molecular analysis that guides precision medical practices. Our research in the field of Aptamers has opened the door to ground-breaking technology in the fields of both diagnostics and therapeutics. Our goal is to help clinicians implement unique precision medicine in their daily practice.